In recent years there have been a number of studies examining the association between coffee and its health benefits. Drinking coffee in moderation is said to offer protection against Parkinson disease, type 2 diabetes, colorectal cancer and Alzheimer's.
And now, you can add one more to that list.
A study conducted by Mayo Clinic suggests that regular consumption of coffee is linked to lower risk of primary sclerosing cholangitis, or PSC, a detrimental liver disease.
Primary sclerosing cholangitis is a chronic disease where the bile ducts become blocked due to inflammation and scarring. It can lead to cirrhosis of the liver, liver failure and biliary cancer.
The new finding was based on a large group of U.S. patients with PSC and primary biliary cirrhosis, or PBC and a group of healthy patients.
According to the study authors, coffee consumption was associated with reduced risk of primary sclerosing cholangitis, but not primary biliary cirrhosis.
Commenting on the findings, Konstantinos Lazaridis, a Mayo Clinic hepatologist and senior study author said, "The study suggests PSC and PBC differ more than originally thought, Moving forward, we can look at what this finding might tell us about the causes of these diseases and how to better treat them."
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.